N-[5-[(2-acetamidoethylamino)methyl]-2-pyridinyl]-2-chloro-3-(3-methoxyphenyl)benzamide
C24H25ClN4O3 — CID 166630297
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[(2-acetamidoethylamino)methyl]-2-pyridinyl]-2-chloro-3-(3-methoxyphenyl)benzamide
N-[5-[(2-acetamidoethylamino)methyl]-2-pyridinyl]-2-chloro-3-(3-methoxyphenyl)benzamide (PubChem CID 166630297) has the molecular formula C24H25ClN4O3 and a molecular weight of 452.94 g/mol. Its IUPAC name is N-[5-[(2-acetamidoethylamino)methyl]-2-pyridinyl]-2-chloro-3-(3-methoxyphenyl)benzamide.
Molecular Properties
| Compound Name | N-[5-[(2-acetamidoethylamino)methyl]-2-pyridinyl]-2-chloro-3-(3-methoxyphenyl)benzamide |
|---|---|
| PubChem CID | 166630297 |
| Molecular Formula | C24H25ClN4O3 |
| Molecular Weight | 452.94 g/mol |
| Exact Mass | 452.16 |
| IUPAC Name | N-[5-[(2-acetamidoethylamino)methyl]-2-pyridinyl]-2-chloro-3-(3-methoxyphenyl)benzamide |
| SMILES | COc1cccc(-c2cccc(C(=O)Nc3ccc(CNCCNC(C)=O)cn3)c2Cl)c1 |
| InChI | InChI=1S/C24H25ClN4O3/c1-16(30)27-12-11-26-14-17-9-10-22(28-15-17)29-24(31)21-8-4-7-20(23(21)25)18-5-3-6-19(13-18)32-2/h3-10,13,15,26H,11-12,14H2,1-2H3,(H,27,30)(H,28,29,31) |
| InChIKey | QCTFWJDAMIUYKH-UHFFFAOYSA-N |
| XLogP | 3.89 |
| TPSA | 92.35 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 452.94 |
| LogP ≤ 5 | 3.89 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166630297 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.